Welcome to the new Gustave Roussy website

A new website designed to offer you a simpler, clearer, and more intuitive experience. Patients, caregivers, healthcare professionals, and donors: find information, news, and services more easily.

News

Goûter en Or 2026, in Paris and Across France : A Nationwide Mobilization Against Childhood Cancer !

Launched in France at the initiative of Gustave Roussy, September Gold, the awareness month dedicated to childhood and adolescent cancers, celebrates its 10th anniversary this year. To mark the occasion, Goûter en Or 2026, the flagship event of the campaign, will take place in numerous cities across France. In Paris, the Jardin d’Acclimatation will host the Grand Goûter en Or for the second consecutive year on Sunday, September 13, 2026, featuring a special musical performance by Skip the Use and the presence of Pierre de Maere, ambassador of Gustave Roussy. Solidarity tickets valid from September 13 through December 31, 2026, are available for purchase.

Published on

Logo Goûter en Or

For the past ten years, every September has been an opportunity for children and adults alike to rally in support of pediatric cancer research and help provide new treatment options and hope for young patients and their families. This year, the Grand Goûter en Or, organized by Gustave Roussy with the support of the Jardin d’Acclimatation, will offer a full day of festive activities from 10 a.m. to 6 p.m. on Sunday, September 13, 2026.
 

Families will be able to enjoy a day of solidarity and entertainment, including wooden games, face painting, balloon sculpting, magic shows and stilt walkers. The Vaillante Show & Marching Band will energize the event with three performances throughout the day, while Pierre de Maere will join attendees in support of the cause. The day will also feature an exceptional live performance by Skip the Use at 4:30 p.m. In addition, 1,000 free solidarity snacks will be distributed to children at 4 p.m.

Across France, the campaign extends well beyond Paris through a network of local partners, including municipalities, childhood support associations and local businesses. Together, they organize solidarity events close to families, such as community snack gatherings, fun walks, cooking workshops, cinema screenings and charity lottery events.

More information about Goûter en Or and the programme of local initiatives is available on the Gustave Roussy website.

Whatever the initiative, the goal remains the same: 100% of the funds raised are entirely dedicated to research into childhood and adolescent cancers.

Grand Goûter en Or

Sunday, September 13, 2026
10 a.m. – 6 p.m.

Jardin d’Acclimatation
Paris 16th arrondissement
Metro: Les Sablons (Line 1)

 

Solidarity ticket sales:

https://gouter-en-or.macollecte.gustaveroussy.fr/

An Essential Mobilization to Advance Research

Each year in France, approximately 2,300 children and adolescents are diagnosed with cancer. Thanks to major advances in research, the five-year survival rate now exceeds 80–85%. However, for young patients who still do not benefit from sufficiently effective treatments, the fight continues.

As the leading comprehensive cancer center in France and Europe, Gustave Roussy plays a major role in pediatric oncology research. Its researchers work to develop new therapies, improve understanding of childhood tumors and deliver innovative treatment options, particularly for cancers that remain difficult to cure.

By supporting Goûter en Or, participants contribute directly to funding research programmes dedicated to improving outcomes and developing new therapeutic solutions for children and adolescents affected by cancer.

To support pediatric cancer research, donations can be made through the dedicated fundraising platform : https://guerirlecancer.gustaveroussy.fr/septembre-en-or/

Last news

  • Breast Cancer: Gustave Roussy Ranked No. 1 in France for Breast Surgery and Breast Reconstruction

    On the occasion of Breast Cancer Awareness Month, the 2025 data from Visuchir, the national surgical activity monitoring tool of the French Health Insurance system, places Gustave Roussy in first position for both breast surgery and breast reconstruction. Beyond this ranking, these figures highlight that reconstruction is now an integral part of breast cancer treatment. It is considered at every stage of care: from tumor removal surgery, whether lumpectomy or mastectomy, through to the post-cancer period, helping to restore the body and support women in regaining their physical integrity and quality of life.

    Photographie - chirurgiens en salle d'opération
  • Newsweek Ranking: Gustave Roussy Named Europe’s Leading Cancer Centre and Third Best Worldwide

    The 2027 edition of Newsweek’s World's Best Specialized Hospitals ranking once again recognises Gustave Roussy as the leading cancer centre in France and Europe, and the third best worldwide. This distinction highlights the excellence of the Institute’s care and research, as well as the daily commitment of all its professionals.

    Badge Word's best specialized hospitals
  • Living with and beyond cancer: the promises and challenges of digital health

    In a Viewpoint article published in The Lancet Digital Health, Drs Ines Vaz-Luis and Maria Alice Franzoi, together with Emmanuel Mussault, a patient partner at the PRISM University Hospital Institute, examine the role that digital tools can play in supporting people living with and beyond cancer. Their central message is that these technologies can support more personalised and accessible care, but their value depends primarily on how they are integrated into care pathways, the human support provided, their ability to address individual needs and their evaluation in real-world settings. 

     Emmanuel Mussault, Ines Vaz-Luis, Maria Alice Franzoi
  • Gustave Roussy and The Lancet launch an international lecture series on innovations transforming cancer care

    The inaugural lecture in the “Lecture Series on Cancer Breakthroughs” will take place on Friday 18 September at 5:00 pm. It will be delivered by Professor Timothy R. Rebbeck, a leading cancer prevention specialist at Harvard University and the Dana-Farber Cancer Institute.

    Flyer évènement - Personalized cancer prevention